MicroRnas in preeclampsia.

Expert Rev Mol Diagn

1st Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens, Greece.

Published: December 2023

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2023.2284780DOI Listing

Publication Analysis

Top Keywords

micrornas preeclampsia
4
micrornas
1

Similar Publications

Preeclampsia is characterized by insufficient invasion of extravillous trophoblasts and is a consequence of failed adaption of extravillous trophoblasts to changes in the intrauterine environment developing embryo. Specific miRNAs are implicated in the development of preeclampsia (PE). miR-455-5p is present at low levels in PE but its role is not known.

View Article and Find Full Text PDF

Pregnancy complications associated with thrombophilia represent significant risks for maternal and fetal health, leading to adverse outcomes such as pre-eclampsia, recurrent pregnancy loss, and intra-uterine growth restriction (IUGR). They are caused by disruptions in key physiological processes, including the coagulation cascade, trophoblast invasion, angiogenesis, and immune control. Recent advancements in epigenetics have revealed that non-coding RNAs, especially microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and extracellular vesicles (EVs) carrying these RNAs, play crucial roles in the regulation of these biological processes.

View Article and Find Full Text PDF

A multi-platform assessment of extracellular vesicles from the plasma and urine of women with preeclampsia.

Placenta

December 2024

Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address:

Introduction: MicroRNAs (miRNAs), packaged within extracellular vesicles (EVs), have been used to interrogate the pathogenesis of preeclampsia and to identify its biomarkers. We have previously shown that miRNA species were differentially expressed in small plasma EVs from women with preeclampsia vs healthy controls. We sought to assess the use of rapid technologies for isolation of plasma and urine EVs from parturients with preeclampsia and determine differences in the expression of selected EV miRNA species.

View Article and Find Full Text PDF

Pre-eclampsia (PE) is a serious condition affecting 2-8% of pregnancies worldwide, leading to high maternal and fetal morbidity and mortality. MicroRNAs (miRNAs), small non-coding RNA molecules, have emerged as potential biomarkers for various pregnancy-related pathologies, including PE. MiRNAs in plasma and serum have been extensively studied, but urinary miRNAs remain underexplored, especially during early pregnancy.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the levels of Vascular Peroxidase 1 (VPO1), humanin, and MOTS-c in untreated preeclamptic pregnancies, focusing on their relationship with miR-200c expression and comparing these findings to endoglin levels.
  • Blood samples from preeclamptic patients showed significantly elevated levels of endoglin, VPO1, and miR-200c, while MOTS-c levels were reduced; humanin levels did not differ significantly.
  • A strong positive correlation was found between endoglin and VPO1, suggesting that these molecular changes may play a role in the pathogenesis of preeclampsia and contribute to endothelial dysfunction.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!